Domain-controlled polymer alloy composed of segmented polyurethane and phospholipid polymer for biomedical applications

Segmented polyurethane(SPU)s are block polymers which have a good elastic property and thermoplasticity. However, the biocompatibility of SPU is not sufficient, and a living organism rejects the SPU as a foreign material. Thus, some modification is needed to provide excellent biocompatibility and retain the good physical characteristics of the SPUs. In this study, we blended the 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer with SPU to prepare an SPU/MPC polymer alloy. We investigated the effects of the molecular weight (M_w) of the MPC polymer on the microdomain structure and mechanical property of the polymer alloy. When the MPC polymer with a higher M_w was blended with SPU, the polymer alloy underwent a reduction in mechanical strength. On the other hand, even when the lower M_w of the MPC polymer was blended with SPU, differential scanning calorimetric analysis revealed that the MPC polymer chains did not disrupt the crystallinity of the hard segments of SPU and the polymer alloy could maintain its physical properties the same as that of the original SPU. We investigated the adsorption of immunoglobulin (IgG) on the surface of the polymer alloy for evaluation of its fundamental biocompatibility. The SPU/MPC polymer alloy lowered the amount of adsorbed IgG compared to that on SPU. This means that the blending of the MPC polymer significantly improved the biocompatibility of the SPU. We succeeded in preparing an SPU/MPC polymer alloy that possesses both the good mechanical property of SPU and the improved biocompatibility using MPC polymers.